Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Neoplasm Recurrence, Local”

424 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 424 results

Not applicableLooking for participantsNCT06382818
What this trial is testing

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 854
Not applicableStudy completedNCT03959839
What this trial is testing

Endoscopic Submucosal Dissection vs Local Laparoscopic Surgical Resection (TAMIS/TEO) in Early Rectal Neoplasias

Who this might be right for
Rectal Neoplasms
Dr. Alberto Herreros de Tejada Echanojáuregui 70
Large-scale testing (Phase 3)Looking for participantsNCT04376866
What this trial is testing

Toripalimab for Local-regional Recurrent Nasopharyngeal Carcinoma

Who this might be right for
Recurrent Nasopharyngeal Carcinoma
Cancer Hospital of Guangxi Medical University 204
Testing effectiveness (Phase 2)Study completedNCT00368875
What this trial is testing

Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer

Who this might be right for
Male Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+1 more
National Cancer Institute (NCI) 54
Testing effectiveness (Phase 2)Study completedNCT00776594
What this trial is testing

Androgen Deprivation Therapy +/- Bevacizumab for PSA Recurrence of Prostate Cancer After Definitive Local Therapy

Who this might be right for
Prostate Cancer
Dana-Farber Cancer Institute 102
Large-scale testing (Phase 3)Study completedNCT00016380
What this trial is testing

Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen

Who this might be right for
Cancer
NCIC Clinical Trials Group 211
Not applicableUnknownNCT03042000
What this trial is testing

Multicenter, Prospective, RCT：Investigation of Combined Modality Therapy for Locally Advanced Mid/Low Rectal Cancer.

Who this might be right for
Rectal Cancer, AdenocarcinomaNeoadjuvant Chemoradiation
Peking Union Medical College Hospital 1,200
Testing effectiveness (Phase 2)Study completedNCT04019964
What this trial is testing

Nivolumab in Biochemically Recurrent dMMR Prostate Cancer

Who this might be right for
Prostate CancerRecurrent Prostate Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 8
Not applicableStudy completedNCT01727011
What this trial is testing

Single Fraction Elderly Breast Irradiation (SiFEBI)

Who this might be right for
Breast Cancer
Centre Antoine Lacassagne 37
Not applicableStudy completedNCT03606616
What this trial is testing

Prospective Feasibility Study Applying the ACOSOG Z0011 Criteria to Chinese Patients

Who this might be right for
Breast CancerSentinel Lymph NodeLocal Recurrence of Malignant Tumor of Breast
Peking University People's Hospital 142
Testing effectiveness (Phase 2)Ended earlyNCT04221438
What this trial is testing

Testing Treatment With Encorafenib and Binimetinib Before Surgery for Melanoma With Lymph Node Involvement

Who this might be right for
Melanoma of Unknown PrimaryMetastatic Malignant Neoplasm in Lymph NodePathologic Stage IIIB Cutaneous Melanoma AJCC v8+3 more
ECOG-ACRIN Cancer Research Group 3
Large-scale testing (Phase 3)Study completedNCT00020501
What this trial is testing

Chemotherapy With or Without Isolated Hepatic Perfusion With Melphalan in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC)
Early research (Phase 1)Looking for participantsNCT07544992
What this trial is testing

Locoregional Administration of Genetically Engineered Cells (EGFR/IL13Rα2 Pool-CAR T Cells) for the Treatment of Recurrent or Progressive High-Grade Gliomas

Who this might be right for
Recurrent Astrocytoma, IDH-Mutant, Grade 4Recurrent Glioblastoma, IDH-Wildtype
City of Hope Medical Center 24
Not applicableStudy completedNCT07353567
What this trial is testing

Long-term Outcomes and Risk Factors of Local Re-Recurrence in Patients

Who this might be right for
Local Re-Recurrence of Malignant Tumor of RectumLocal Recurrence of Malignant Tumor of Rectum
Sixth Affiliated Hospital, Sun Yat-sen University 298
Early research (Phase 1)Study completedNCT00450307
What this trial is testing

Monoclonal Antibody 3F8 and GM-CSF in Treating Young Patients With High-Risk, Refractory or Relapsed Neuroblastoma

Who this might be right for
Neuroblastoma
Memorial Sloan Kettering Cancer Center 32
Testing effectiveness (Phase 2)UnknownNCT00081536
What this trial is testing

Aroplatin and Capecitabine in Patients With Advanced Colorectal Cancer Resistant to Standard Therapies

Who this might be right for
Colorectal Neoplasms
Aronex Pharmaceuticals 105
Not applicableLooking for participantsNCT04881487
What this trial is testing

Additional Treatment for Isolated Local Pancreatic Cancer Recurrence Using Stereotactic Body Radiation Therapy

Who this might be right for
Recurrent Pancreatic Ductal Adenocarcinoma
UMC Utrecht 174
Testing effectiveness (Phase 2)UnknownNCT03294486
What this trial is testing

Safety and Efficacy of the ONCOlytic VIRus Armed for Local Chemotherapy, TG6002/5-FC, in Recurrent Glioblastoma Patients

Who this might be right for
GlioblastomaBrain Cancer
Assistance Publique - Hôpitaux de Paris 78
Large-scale testing (Phase 3)UnknownNCT00410631
What this trial is testing

Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma

Who this might be right for
Neuroblastoma
German Society for Pediatric Oncology and Hematology GPOH gGmbH 642
Not applicableUnknownNCT06356441
What this trial is testing

Artificial Intelligence-supported Reading Versus Standard Double Reading for the Interpretation of Magnetic Resonance Imaging in the Detection of Local Recurrence for Nasopharyngeal Carcinoma: a Randomised Controlled Multicenter Study

Who this might be right for
Artificial Intelligence Supported Image Reviewing
Sun Yat-sen University 10,400
Load More Results